Summary
Liver fat reduction in HIV
Study Details
Study Design
Phase 3 RCT
Indication
NAFLD in HIV
Intervention
Tesamorelin 2 mg SC daily
Species
Human
Tags
SourceRCTPhase3TesamorelinNAFLDHIVLancet
Metrics
Citations
0Evidence QualityN/A
Related PeptideTesamorelin6 papers